<span><b>Background:</b> Accumulating evidence suggests that the non-intoxicating cannabinoid compound cannabidiol (CBD) may have antipsychotic and anxiolytic properties, and thus may be a promising new agent in the treatment of psychotic and anxiety disorders. However, the neurobiological substrates unde</span> … Current research suggest it can be both helpful and harmful to memory – here’s why. Currently there is no evidence to show that cannabis or cannabis oil (CBD oil) can stop, reverse or prevent dementia.
The Impact of Cannabidiol on Human Brain Function: A Systematic Review
Background: Accumulating evidence suggests that the non-intoxicating cannabinoid compound cannabidiol (CBD) may have antipsychotic and anxiolytic properties, and thus may be a promising new agent in the treatment of psychotic and anxiety disorders. However, the neurobiological substrates underlying the potential therapeutic effects of CBD are still unclear. The aim of this systematic review is to provide a detailed and up-to-date systematic literature overview of neuroimaging studies that investigated the acute impact of CBD on human brain function. Methods: Papers published until May 2020 were included from PubMed following a comprehensive search strategy and pre-determined set of criteria for article selection. We included studies that examined the effects of CBD on brain function of healthy volunteers and individuals diagnosed with a psychiatric disorder, comprising both the effects of CBD alone as well as in direct comparison to those induced by ∆9-tetrahydrocannabinol (THC), the main psychoactive component of Cannabis. Results: One-ninety four studies were identified, of which 17 met inclusion criteria. All studies investigated the acute effects of CBD on brain function during resting state or in the context of cognitive tasks. In healthy volunteers, acute CBD enhanced fronto-striatal resting state connectivity, both compared to placebo and THC. Furthermore, CBD modulated brain activity and had opposite effects when compared to THC following task-specific patterns during various cognitive paradigms, such as emotional processing (fronto-temporal), verbal memory (fronto-striatal), response inhibition (fronto-limbic-striatal), and auditory/visual processing (temporo-occipital). In individuals at clinical high risk for psychosis and patients with established psychosis, acute CBD showed intermediate brain activity compared to placebo and healthy controls during cognitive task performance. CBD modulated resting limbic activity in subjects with anxiety and metabolite levels in patients with autism spectrum disorders. Conclusion: Neuroimaging studies have shown that acute CBD induces significant alterations in brain activity and connectivity patterns during resting state and performance of cognitive tasks in both healthy volunteers and patients with a psychiatric disorder. This included modulation of functional networks relevant for psychiatric disorders, possibly reflecting CBD’s therapeutic effects. Future studies should consider replication of findings and enlarge the inclusion of psychiatric patients, combining longer-term CBD treatment with neuroimaging assessments.
Keywords: Cannabis (marijuana); cannabidiol; delta9-tetrahydrocannabinol; functional MRI; neuroimaging.
Copyright © 2021 Batalla, Bos, Postma and Bossong.
Conflict of interest statement
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Does cannabis really affect memory? Here’s what research currently says
Elizabeth Hughes receives funding from National Institute for Health Research.
Ian Hamilton does not work for, consult, own shares in or receive funding from any company or organisation that would benefit from this article, and has disclosed no relevant affiliations beyond their academic appointment.
University of Leeds provides funding as a founding partner of The Conversation UK.
University of York provides funding as a member of The Conversation UK.
THC and CBD, both cannabis compounds, have very different effects on the brain. Dmytro Tyshchenko/ Shutterstock
Cannabis use has long been associated with memory loss. But until now, this notion was largely anecdotal. As researchers begin to look into cannabis and the effect that it has on human health, they’re beginning to better understand the effect it has on the human brain – and whether cannabis really does impair memory.
Memory is divided into both short-term and long-term memory. Short-term memory is where immediate events are temporarily stored, whereas long-term memory is where information is stored indefinitely.
Current evidence shows that cannabis intoxication may temporarily alter or distort short-term memory processing. This seems to be caused by compounds in cannabis that disrupt neural signalling when binding to receptors responsible for memory in the brain. Interrupted short-term memory can indeed impact on learning, and may also cause loss of interest or problems with concentration.
However, early research also shows that cannabis could have a positive impact on neurodegenerative diseases that affect memory, such as Alzheimer’s, Huntington Chorea, and epilepsy. In mainly animal studies, when researchers used components found in cannabis, they found it could slow or even prevent the advance of these diseases – essentially through the creation of neurons.
These apparently paradoxical effects from the same drug are best explained by two chemicals found in cannabis. Namely delta 9-tetrahydrocannabinol (THC) and cannabidiol (CBD). We all have naturally occurring cannabinoid receptors in our brains. THC is able to effectively bind to these receptors, creating euphoric effects. However CBD can interfere with this binding process, which dampens the feeling of euphoria.
Different ratios of these two chemicals are found in various types of cannabis. Consuming a cannabis product with THC but no CBD increases the risk of developing mental health problems, such as psychosis. However, CBD could actually be used to treat psychosis.
Cannabis with higher levels of THC and lower, or negligible, amounts of CBD appear to have a detrimental effect on short-term memory, particularly in adolescents. The main problem is their ability to retain and recall information. Fortunately this is not permanent.
But these recent discoveries about the role of THC and CBD in cannabis show that we can no longer simply say cannabis itself causes psychosis, or is detrimental to memory. Rather, it might be the type of cannabis, and the compounds it contains, that may have specific risks or benefits.
And while there’s little doubt that some people who use cannabis do experience impaired memory, establishing that cannabis is the cause is tricky. One reason for this is because it’s difficult to rule out the impact of other drugs that people may have used – and whether these drugs contributed to this memory impairment. For example, alcohol misuse can also cause brain damage and memory loss. Another obvious problem when researching this is when asking people with impaired memory to recall their past drug use and any associated problems. Their ability to recall these details could be compromised.
Recent research even suggests that any memory impairment associated with using cannabis can be reversed when people stop using cannabis. This effect was seen mainly in those who used cannabis at least once a week.
Just as higher doses of alcohol can potentially cause brain damage, higher doses or more frequent use of cannabis may also cause long-term memory problems – the ability to learn effectively and the ability to concentrate on a task for example. Some people will use both alcohol and cannabis, often at the same time, which may both worsen the potential impact on memory.
New research also suggests that it’s cannabis, rather than alcohol, that’s responsible for damage to developing teen brains. Though alcohol can destroy or severely damage brain neurons and their signalling functions, this study showed cannabis actually changes the neural brain tissue responsible for memory. But this change can be reversed within a matter of weeks if a person abstains. Though surveys suggest fewer young people are using both cannabis and alcohol, those teenagers that do use cannabis use it twice as frequently.
Frequent cannabis by teens may impact their memory and ability to concentrate. mooremedia/ Shutterstock
Research shows that young, frequent users of cannabis have thinner temporal and frontal cortices, which are both areas that help process memory functioning. Memory is a critical aid to learning and study – but cannabis doesn’t just effect memory, it can also reduce motivation to learn. This dual influence reduces a young person’s engagement in education and their ability to perform.
However, using cannabis later in life (age 50 and over) appears to have only a moderate impact on cognitive functioning, including on memory. These modest declines are not fully understood, and there is a lack of high quality research in this area. That will need to change as it’s not just young people that use cannabis. As more countries legalise cannabis, older people might also want to try it.
While there is likely to be no great harm to a person’s memory if they experiment with cannabis, current research seems to agree that the more frequent the use, the greater the risk. Though there is still a lot that researchers don’t yet know about cannabis use on memory, current evidence suggests that any memory impairment can be reversed if a person abstains from use.
Cannabis, CBD oil and dementia Cannabis, CBD oil and dementia .
Currently there is no evidence to show that cannabis or cannabis oil (CBD oil) can stop, reverse or prevent dementia.
Can cannabis or CBD oil treat dementia or its symptoms?
There are no research studies that prove cannabis, or products such as cannabis oil (CBD oil), can stop, slow, reverse or prevent the diseases that cause dementia.
Some studies suggest cannabis could help to manage a few behavioural symptoms of dementia, such as agitation and aggression.
But more research is needed to understand the long-term effects of taking cannabis, and whether it is an effective and safe way to tackle dementia symptoms.
If you have any questions or concerns about cannabis use and the risk of dementia or other brain disorders, please talk to your GP.
Read our advice to help reduce your risk of developing dementia.
What is cannabis?
Coconut oil and dementia Coconut oil and dementia .
There is currently a lack of evidence to show that coconut oil plays any role in preventing or treating dementia or its symptoms.
Cannabis, also known as marijuana, is a plant. The dried leaves, flowering parts or resin extracted from the plant is taken recreationally.
Cannabis is made up for two main components – Tetrahydrocannabinol and Cannabidiol.
What is Tetrahydrocannabinol (THC)?
THC is the main component of cannabis that invokes feelings of sociability, happiness or relaxation.
Products containing more than 0.2% THC are not legally available in the UK.
What is Cannabidiol (CBD)?
Cannabidiol or CBD does not cause any psychoactive or intoxicating effects.
Products that contain CBD are legal and can be bought on the high street or online.
Is there any evidence behind the cannabis and CBD oil claims?
There have been no clinical trials on the effects of cannabis or CBD oil in people living with dementia.
In the lab
A key hallmark of Alzheimer’s disease is the build up of clumps of a protein, called amyloid, in the brain. Some studies have shown that components of cannabis, including THC, appear to remove this protein from nerve cells grown in the lab.
Another study that gave both THC and CBD oil to mice with symptoms of Alzheimer’s disease showed an improved in learning and had less evidence of amyloid clumps in their bodies.
Research continues to better understand the effects of CBD oil on the brain. Some early evidence suggests that CBD oil may reduce inflammation in the brain, although this has yet to be proven in people.
5 clinical trial myth busters 5 clinical trial myth busters .
We tackle the 5 most common myths surrounding clinical trials and explain why clinical trials are vital for driving dementia research forward. We tackle the 5 most common myths surrounding clinical trials and explain why clinical trials are vital for driving dementia research forward. .
Tackling the symptoms of dementia
Research does suggest that high concentrations of CBD oil could be useful for managing some of the symptoms of dementia such as agitation and anxiety.
A few small clinical trials have assessed the effects of cannabinoids (including THC and synthetic cannabinoids, such as nabilone) on behavioural symptoms of dementia. However, trials and studies so far have generally been small or low quality making it difficult to come to a conclusion.
It is also important to note that the researchers in these studies have used high concentrations of CBD oil that may not be available to buy. These studies have also been short term so we still don’t know what the long term effects of using CBD oil might be.
A study is currently underway at King’s College London that will look at whether a mouth spray containing cannabinoids could be used to reduce symptoms of agitation and aggression in a small group of people with Alzheimer’s disease.